ALT5 Sigma Corporation Stock Price, News & Analysis

ALT5 Sigma (NASDAQ:ALTS) has announced its participation in the upcoming iFX EXPO Dubai at the Dubai World Trade Centre from January 14-16, 2025. The company will showcase at booth #26, offering product demonstrations and solutions to over 7,000 expected attendees.

ALT5 Sigma, a fintech company listed on Nasdaq and part of the Russell Microcap Index, provides blockchain-powered technologies for digital assets. Through its subsidiary ALT5 Sigma Inc., the company operates two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform. The company processed over US$1.2 billion in cryptocurrency transactions in 2023.

The company also maintains biotech activities focused on developing solutions to address the opioid crisis, with drugs in clinical trials targeting pain management alternatives to addictive opioids.

ALT5 Sigma (NASDAQ:ALTS) announced the approval of all proposed resolutions at its 2024 AGM, including the re-election of board members and the election of CEO Peter Tassiopoulos to the Board. The company reported achieving record transaction volumes exceeding US$2 billion in 2024 through its ALT5 Pay and Prime platforms.

The company plans to spin-off its healthcare assets into Alyea Therapeutics in the first half of 2025. Alyea has executed a non-binding LOI to acquire Soin Bioscience , which would bring innovative clear patch pain medication technology to its portfolio. The global pain patch market is projected to grow from US$4.80 billion in 2021 to US$7.33 billion by 2031.

ALT5 Sigma (NASDAQ:ALTS) reported strong Q3 2024 financial results with record revenue of $4.94 million and gross profit of $2.39 million in its fintech segment. The company achieved a fintech net income of $714k and Adjusted EBITDA of $889k. Cash and equivalents stood at $8.67 million. The company plans to separate its biotech business, Alyea Therapeutics, in the first half of 2025, with intentions to finance Alyea's operations separately. Transaction volume exceeded $600 million for Q3. The company recently acquired additional IP to enhance features planned for Q4 and fiscal 2025.

ALT5 Sigma (NASDAQ:ALTS) has appointed Ron Pitters to its Board of Directors. Pitters, currently serving as CAO of Axos Clearing and President of Axos Business Center Corp., brings over 20 years of experience in fintech, financial services, and emerging technologies. His global business management experience spans Asia, the Middle East, Europe, and the USA.

ALT5 Sigma, a fintech innovator providing blockchain-powered technologies, processed over US$1.2 billion in cryptocurrency transactions in 2023 through its platforms ALT5 Pay and ALT5 Prime. The company is also developing innovative solutions for the opioid crisis through its biotech division.

ALT5 Sigma (NASDAQ:ALTS) announces its participation in Spartan Capital Securities' inaugural investor conference scheduled for November 4th at the Pierre Hotel in New York. The event will feature presentations from over 30 selected companies, including panel discussions, one-on-one meetings, and networking sessions. The conference, organized in partnership with B2i Digital, aims to facilitate interactions between companies and Spartan Capital's investor base. ALT5's CRO Vay Tham will present the company's growth strategy and market position to key capital market influencers.

ALT5 Sigma (NASDAQ:ALTS) announced its participation in the upcoming Money20/20 Las Vegas conference from October 27-30, 2024. The company will exhibit at booth #11713 at The Venetian Resort, providing product demonstrations and solutions to over 12,000 attendees. Money20/20 USA is the largest gathering of the global money ecosystem, including banks, payments, tech, startups, and fintech. ALT5 Sigma's CRO Vay Tham highlighted the company's growing volumes in crypto payments, positioning them as an innovator in the payments ecosystem.

ALT5 Sigma (NASDAQ:ALTS) reported a record transaction volume of over $240 million for September 2024, representing a 151% year-over-year increase from September 2023. The company's year-to-date transaction volume reached approximately $1.5 billion, with Q3 exceeding $600 million, marking a record quarter. ALT5 Sigma, a fintech company providing blockchain-powered technologies for digital asset services, attributes this growth to realigned sales and marketing efforts, global tradeshow presence, new customer onboardings, and increased flows from existing customers.

The company offers two main platforms: ALT5 Pay, a cryptocurrency payment gateway, and ALT5 Prime, an electronic over-the-counter trading platform for digital assets. In 2023, ALT5 Sigma processed over $1.2 billion in cryptocurrency transactions. The company is also involved in biotech activities, focusing on developing innovative solutions to address the opioid crisis.

ALT5 Sigma (NASDAQ:ALTS) has announced a strategic plan to separate into two independent publicly traded companies. The separation will result in ALT5 continuing as a leading fintech organization, while the Biotech segment will become Alyea Therapeutics , focusing on non-addictive pain management therapies.

Key benefits of the separation include:

• Increased focus and agility within respective industries
• Tailored capital allocation strategies
• Enhanced strategic flexibility for M&A
• Unique investment profiles for diverse investor bases
• Distinct boards and management teams

ALT5 will maintain its focus on blockchain-powered technologies, offering ALT5 Pay and ALT5 Prime platforms. Alyea Therapeutics will develop non-addictive pain management therapies, with its lead candidate JAN123 receiving FDA orphan drug designation.

ALT5 Sigma (NASDAQ:ALTS), a fintech company specializing in blockchain-powered technologies for digital asset management, has reported impressive growth in its transaction volume. For August 2024, the company's transaction volume reached US$192 million, marking a 120% year-over-year increase from August 2023's $87 million. The year-to-date transaction volume for the first eight months of 2024 stands at US$1.250 billion, representing a 104% year-over-year increase. This substantial growth demonstrates ALT5's strong performance in the digital asset space and its ability to capitalize on the increasing demand for blockchain-based financial solutions.